Dovitinib

• Description:

  A novel, multitargeted RTK inhibitor of class III, IV, and V RTKs.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  392.4294

• Molecular Formula:

  C21H21FN6O

• Notes:

  Research use only, not for human use.

• Receptor:

  C-Kit|FGFR1|FGFR3|FLT3|VEGFR3/FLT4

• CAS Number:

  405169-16-6